Skip to content

Persistence rate of out-patients visit in glaucoma patients

Persistence rate of out-patients visit in glaucoma patients - Persistence rate of out-patients visit in glaucoma patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000030169
Enrollment
120
Registered
2017-11-30
Start date
2017-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Interventions

None listed

Sponsors

Santen Pharmaceutical Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Phase 1 Newly diagnosed glaucoma patients for April 2016 to May 2016 at clinics introducing of tool. Phase 2 Newly diagnosed glaucoma patients for April 2017 to May 2017 at clinics which persistence rate of out-patients visit is under 70.0% in Phase 1.

Exclusion criteria

Exclusion criteria: Not applicable

Design outcomes

Primary

MeasureTime frame
Persistence rate of out-patients visit after loading tool.

Countries

Japan

Contacts

Public ContactNaomi Otsuka

Santen Pharmaceutical Co., Ltd. Japan Medical Affairs, Development Management Department, Japan Business

clinical@santen.co.jp06-4802-9603

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026